Over 50 million US patients suffer from osteoarthritis, with no drugs available to arrest the disease. Learn more about our investigational drug candidate, lorecivivint.

Learn More
Privacy Policy Terms of Use Contact Us © Biosplice Therapeutics, Inc. All rights reserved.